These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1479048)

  • 1. Characteristics of long-term alprazolam users in the community.
    Romach MK; Somer GR; Sobell LC; Sobell MB; Kaplan HL; Sellers EM
    J Clin Psychopharmacol; 1992 Oct; 12(5):316-21. PubMed ID: 1479048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication discontinuation in panic disorder.
    Ballenger JC; Pecknold J; Rickels K; Sellers EM
    J Clin Psychiatry; 1993 Oct; 54 Suppl():15-21; discussion 22-4. PubMed ID: 8262887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of alprazolam after long-term treatment of panic-related disorders.
    DuPont RL; Swinson RP; Ballenger JC; Burrows GD; Noyes R; Rubin RT; Rifkin A; Pecknold JC
    J Clin Psychopharmacol; 1992 Oct; 12(5):352-4. PubMed ID: 1479053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of chronic use of alprazolam and lorazepam.
    Romach M; Busto U; Somer G; Kaplan HL; Sellers E
    Am J Psychiatry; 1995 Aug; 152(8):1161-7. PubMed ID: 7625464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term alprazolam use: abuse, dependence or treatment?
    Romach MK; Busto UE; Sobell LC; Sobell MB; Somer GR; Sellers EM
    Psychopharmacol Bull; 1991; 27(3):391-5. PubMed ID: 1775614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
    Risse SC; Whitters A; Burke J; Chen S; Scurfield RM; Raskind MA
    J Clin Psychiatry; 1990 May; 51(5):206-9. PubMed ID: 2335496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alprazolam in panic disorder: a retrospective analysis.
    Shelton RC; Harvey DS; Stewart PM; Loosen PT
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):423-34. PubMed ID: 8475324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alprazolam and benzodiazepine dependence.
    Sellers EM; Ciraulo DA; DuPont RL; Griffiths RR; Kosten TR; Romach MK; Woody GE
    J Clin Psychiatry; 1993 Oct; 54 Suppl():64-75; discussion 76-7. PubMed ID: 8262891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC
    J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam.
    Albeck JH
    J Clin Psychiatry; 1987 Oct; 48 Suppl():43-9. PubMed ID: 2889723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alprazolam and depression: a review of risks and benefits.
    Kravitz HM; Fawcett J; Newman AJ
    J Clin Psychiatry; 1993 Oct; 54 Suppl():78-84; discussion 85. PubMed ID: 8262892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?
    Spiegel DA; Bruce TJ; Gregg SF; Nuzzarello A
    Am J Psychiatry; 1994 Jun; 151(6):876-81. PubMed ID: 8184997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication discontinuation in panic disorder.
    Ballenger JC
    J Clin Psychiatry; 1992 Mar; 53 Suppl():26-31. PubMed ID: 1548252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacology of the anxiety disorders.
    Ballenger JC
    Psychiatr Clin North Am; 1984 Dec; 7(4):757-71. PubMed ID: 6151647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.